Pacira BioSciences (PCRX) Non-Current Deferred Tax Liability (2025 - 2026)
Pacira BioSciences (PCRX) posted quarterly Non-Current Deferred Tax Liability of $4.1 million for Q1 2026, down 41.5% year-over-year from $7.0 million in Q1 2025, and down 2.85% quarter-over-quarter from $4.2 million in Q4 2025.
Pacira BioSciences (PCRX) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends
Pacira BioSciences' Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 41.5% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 41.5% YoY), while the FY2025 annual figure was $4.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $4.1 million, down from $4.2 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $7.0 million in Q1 2025, with the low at $4.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Pacira BioSciences | 939.59 Mn | 688.56 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.07 Mn |
| Jun 30, 2026 | 4.07 Mn |
| Mar 31, 2026 | 4.09 Mn |
| Mar 31, 2026 | 4.09 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.00 Mn |